全文获取类型
收费全文 | 729篇 |
免费 | 91篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 17篇 |
妇产科学 | 5篇 |
基础医学 | 147篇 |
口腔科学 | 3篇 |
临床医学 | 70篇 |
内科学 | 133篇 |
皮肤病学 | 13篇 |
神经病学 | 90篇 |
特种医学 | 14篇 |
外科学 | 32篇 |
综合类 | 17篇 |
预防医学 | 72篇 |
眼科学 | 3篇 |
药学 | 180篇 |
中国医学 | 3篇 |
肿瘤学 | 19篇 |
出版年
2022年 | 7篇 |
2021年 | 16篇 |
2019年 | 15篇 |
2018年 | 6篇 |
2016年 | 8篇 |
2015年 | 12篇 |
2014年 | 15篇 |
2013年 | 20篇 |
2012年 | 24篇 |
2011年 | 34篇 |
2010年 | 17篇 |
2009年 | 21篇 |
2008年 | 37篇 |
2007年 | 42篇 |
2006年 | 34篇 |
2005年 | 31篇 |
2004年 | 36篇 |
2003年 | 42篇 |
2002年 | 29篇 |
2001年 | 21篇 |
2000年 | 27篇 |
1999年 | 22篇 |
1998年 | 10篇 |
1997年 | 5篇 |
1996年 | 9篇 |
1994年 | 6篇 |
1993年 | 6篇 |
1992年 | 13篇 |
1991年 | 14篇 |
1990年 | 30篇 |
1989年 | 17篇 |
1988年 | 12篇 |
1987年 | 16篇 |
1986年 | 9篇 |
1985年 | 12篇 |
1984年 | 5篇 |
1981年 | 4篇 |
1980年 | 4篇 |
1979年 | 5篇 |
1978年 | 12篇 |
1977年 | 9篇 |
1976年 | 11篇 |
1975年 | 11篇 |
1974年 | 5篇 |
1973年 | 6篇 |
1972年 | 5篇 |
1970年 | 12篇 |
1969年 | 6篇 |
1968年 | 10篇 |
1967年 | 6篇 |
排序方式: 共有820条查询结果,搜索用时 31 毫秒
101.
A modified primate model of Parkinson's disease was developed to assess the effectiveness of various agents that act via dopamine, acetylcholine, serotonin or glutamate systems. Using a MPTP dosing regimen a reversible parkinsonian-like syndrome was produced in the marmoset. An obvious advantage of such a protocol is that it allows multiple drug studies to be undertaken in animals, without the need for prolonged anti-parkinsonian therapy to maintain their health. Results show that dopamine D2 agonists (bromocriptine, quinpirole, N,N-dipropyl,A,5,6-DTN, (+)3PPP and PHNO), anti-muscarinics (atropine, scopolamine and benztropine), in addition tol-DOPA and nomifensine, all reduced the bradykinesia induced by MPTP. The D1 agonist SKF-38393 and the partial dopamine agonist (–)3PPP were both ineffective. Finally, agents with potential therapeutic use in Parkinson's disease were also tested. However, a glutamate antagonist (MK801) and three serotonin antagonists (ritanserin, ketanserin and ICI 170,809) were all unable to alter the MPTP effects, at the doses used in our study. 相似文献
102.
103.
Counter-ion binding to mucus glycoproteins 总被引:1,自引:0,他引:1
The affinity of pig gastric mucus glycoprotein for counter ions of various valencies was examined. Ions of higher valency were bound with increasing avidity, but the degree of binding was apparently not influenced by the ionic radius. The affinity of the glycoprotein for the ions studied may be ranked: Fe3+ greater than Al3+ greater than Ca2+ greater than Cs+ congruent to Na+. The binding of calcium was inhibited by high ionic strength and was sensitive to the pH of the environment. Enzymatic removal of sialic acid slightly reduced the calcium binding capacity. 相似文献
104.
105.
B. M. McIIveen R. Hoschl I. P. C. Murray R. M. McCredie P. Chidiac D. Marriott J. Beveridge 《Internal medicine journal》1978,8(4):500-508
Summary: In order to evaluate the clinical usefulness of radionuclide methods measuring the magnitude of left-to-right cardiac shunts, a comparison has been made of the results obtained using these procedures with those estimated by cardiac catheterization. Seventy children in whom the presence or absence of a shunt had been established, were studied. Two methods for radionuclide shunt quantitation, the pulmonary to systemic blood flow ratio (Qp/Qs) of Maltz and Treves and their modified C2/C1, were evaluated. The former was found to be superior and showed a high correlation of shunt size with the catheter results. With attention to the performance of the investigation and in the data analysis, good discrimination can be achieved between normal patients and those with shunts. Because of the atraumatic nature of the investigation, it is concluded that the procedure is of value in the diagnosis of a cardiac murmur, the assessment of post- operative patients and the follow-up of patients known to have a small shunt. 相似文献
106.
107.
Murnane D Martin GP Marriott C 《Journal of pharmaceutical and biomedical analysis》2006,40(5):1149-1154
The analysis of weakly basic drugs such as salmeterol xinafoate (SX) by reverse-phase liquid chromatography remains a problem, particularly when present in combination with other drugs such as steroids and weak acids. This study describes the validation of an assay for a weakly basic drug, salmeterol (SB), its weakly acidic counter-ion, 1-hydroxy-2-naphthoic acid (XA), and the neutral glucocorticoid, fluticasone propionate (FP) using a second-generation silica stationary phase (Inertsil ODS-2). The assay utilized an Inertsil ODS-2 base-deactivated 250 mm × 4.6 mm, 5 μm HPLC column, with 75:25 methanol:0.6% aqueous ammonium acetate as the mobile phase. Under these near neutral conditions, SB demonstrated a good peak shape (tailing factor = 1.21 ± 0.02, n = 85). The method provided a short analysis time: XA, tR = 2.96 min; SB, tR = 5.23 min and FP, tR = 7.01 min. The assay displayed good sensitivity for both XA (LOD for SX = 0.22 μg mL−1) and SB (LOD for SX = 0.26 μg mL−1). The limit of detection for FP was 0.19 μg mL−1. Neither of the drugs was found to interfere in the determination of the other and the assay accuracy (% recovery) was high (the recoveries were: 99.58 ± 1.85% for XA, 99.49 ± 1.88% for SB and 100.24 ± 1.28% for FP). The assay reproducibility was determined with a mean coefficient of variance for the five calibration concentrations of XA = 0.71 ± 0.18%; SB = 1.11 ± 0.64% and FP = 0.92 ± 0.14%. Analysis of a pressurized metered dose inhaler formulation demonstrated recovery of the analytes that are within pharmacopoeial limits. It was shown that RP-HPLC was suitable for the high throughput analysis of the combination of SX and FP. 相似文献
108.
Defective interfering (DI) virus RNAs result from major deletions in full-length viral RNAs that occur spontaneously during de novo RNA synthesis. These RNAs are packaged into virions that are by definition non-infectious, and are delivered to cells normally targeted by the virion. DI RNAs can only replicate with the aid of a coinfecting infectious helper virus, but the small size of DI RNA allows more copies of it to be made than of its full-length counterpart, so the cell produces defective virions in place of infectious progeny. In line with this scenario, the expected lethal disease in an influenza A virus-mouse model is made subclinical by administration of DI virus, but animals develop solid immunity to the infecting virus. Hence DI virus has been called an 'interfering vaccine'. Because interfering vaccine acts intracellularly and at a molecular level, it should be effective against all influenza A viruses regardless of subtype. Here we have used the ferret, widely acknowledged as the best model for human influenza. We show that an interfering vaccine with defective RNAs from an H3N8 virus almost completely abolished clinical disease caused by A/Sydney/5/97 (H3N2), with abrogation of fever and significant reductions in clinical signs of illness. Animals recovered fully and were solidly immune to reinfection, in line with the view that treatment converts the otherwise virulent disease into a subclinical and immunizing infection. 相似文献
109.
110.
H J Marriott 《Geriatrics》1970,25(11):91-101